Results 111 to 120 of about 20,705 (157)

Response to: Letter to the Editor Regarding 'Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study'. [PDF]

Adv Ther
Alcázar-Navarrete B, Figueira-Gonçalves JM, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +4 more
europepmc   +1 more source

Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation. [PDF]

Respir Res, 2022
Suraya R, Nagano T, Ryanto GRT, Effendi WI, Hazama D, Katsurada N, Yamamoto M, Tachihara M, Emoto N, Nishimura Y, Kobayashi K.   +10 more
europepmc   +1 more source

Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in patients with tuberculosis-associated chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. [PDF]

J Thorac Dis
Wu F, Huang S, Lei M, Deng Z, Wan Q, Tang G, Zhou K, Liang X, Abduwaiti T, Turgon R, Zhang K, Turgon K, Li Y, Li H, Zou W.   +14 more
europepmc   +1 more source

Lung Deposition of Inhaled Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide in Healthy Volunteers and Asthma: The STORM Study. [PDF]

J Aerosol Med Pulm Drug Deliv, 2022
Usmani OS, Baldi S, Warren S, Panni I, Girardello L, Rony F, Taylor G, DeBacker W, Georges G.   +8 more
europepmc   +1 more source

Formoterol in the management of chronic obstructive pulmonary disease

, 2008
Paschalis Steiropoulos, Argyris Tzouvelekis, Demosthenes BourosDepartment of Pneumonology, University Hospital of Alexandroupolis, GreeceAbstract: Bronchodilators represent the hallmark of symptomatic treatment of Chronic Obstructive Pulmonary Disease ...
Argyris Tzouvelekis, Paschalis Steiropoulos, Demosthenes Bouros   +2 more
core  

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study. [PDF]

Adv Ther
Alcázar-Navarrete B, Figueira-Gonçalves JM, Corregidor-García C, Fitas E, Sánchez-Covisa J, ORESTES group.   +5 more
europepmc   +1 more source

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study. [PDF]

Pulm Ther
Figueira-Gonçalves JM, Alcázar-Navarrete B, Casitas-Mateo R, González J, Gotera-Rivera CM, Herrejón-Silvestre A, Margallo-Iribarnegaray J, Martín-Lana M, Pallarés-Sanmartín A, Pascual-Guardia S, Saura-Vinuesa A, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +13 more
europepmc   +1 more source

An Insight Into the Aerosolization Pattern of Formoterol Fumarate Dry Powder Inhalation Formulation Actuated Via Two Different Inhaler Devices. [PDF]

Adv Pharm Bull
Asadollahi L, Ghanbari R, Abbaspour-Ravasjani S, Hamishehkar H, Nokhodchi A.   +4 more
europepmc   +1 more source

Correction to: Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England. [PDF]

Adv Ther
Woodcock A, Blakey J, Bourdin A, Canonica GW, Domingo C, Ford A, Hulme R, Tritton T, Palomares I, Sadhu S, Biswas A, Verma M.   +11 more
europepmc   +1 more source

Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma. [PDF]

Adv Respir Med
Maiorano A, Ferrante Bannera A, Lupia C, Pastore D, Chiarella E, Piazzetta GL, Maglio A, Vatrella A, Pelaia G, Pelaia C.   +9 more
europepmc   +1 more source